BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6203070)

  • 1. Detection of malignant ovarian neoplasms: a review of the literature. II. Laboratory detection.
    Smith LH; Oi RH
    Obstet Gynecol Surv; 1984 Jun; 39(6):329-45. PubMed ID: 6203070
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of tumor markers in cancer of the ovary.
    Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
    Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical value of the determination of pregnancy proteins in the blood].
    Kamińska JA; Ozuch B
    Ginekol Pol; 1981 Apr; 52(4):381-91. PubMed ID: 6167491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers. Current knowledge and practical usefulness].
    Papaleo G; Sacerdoti G; Zito GA
    Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719
    [No Abstract]   [Full Text] [Related]  

  • 9. Serial determination of marker substances in ovarian cancer.
    Stanhope CR; Smith JP; Britton JC; Crosley PK
    Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum markers in malignant diseases].
    Peter HH
    Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetal and placental proteins in ovarian cancer].
    Tatra G; Ludwig H
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of malignant diseases using tumor markers].
    Schneider J
    Biomed Tech (Berl); 1984 Nov; 29(11):278-82. PubMed ID: 6210115
    [No Abstract]   [Full Text] [Related]  

  • 18. Ovarian tumours markers: clinical experiences.
    Maggino T; Tredese F; Paternoster D; Marchesoni D; Valente S; Inguscio D; Marchetti M
    Eur J Gynaecol Oncol; 1982; 3(2):81-7. PubMed ID: 6187572
    [No Abstract]   [Full Text] [Related]  

  • 19. [New developments in the area of markers in diagnosis and monitoring of ovarian cancer].
    Kreienberg R; Melchert F
    Onkologie; 1985 Oct; 8(5):253-9. PubMed ID: 2415891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor antigens in ovarian malignancy.
    Rubin SC; Lewis JL
    Clin Obstet Gynecol; 1986 Sep; 29(3):693-704. PubMed ID: 2428553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.